On Tuesday, Paychex, Inc. (NASDAQ:PAYX)’s shares inclined 2.87% to $45.58.
The Paychex | IHS Small Business Jobs Index reduced 0.17 percent from July to August, bringing the national index to 100.48. Little movement in recent months gave way to August’s decline. The index was down 0.51 percent from August 2014. The East North Central continued as the top-performing regional index despite a slight decrease month over month. Wisconsin surpassed Washington to lead among states tracked by the index, while Dallas has continued success as the top-ranked metro area for 11 straight months.
Paychex, Inc. provides payroll, human resource, insurance, and benefits outsourcing solutions for small to medium-sized businesses in the United States and Germany. The company offers payroll processing services that comprise the calculation, preparation, and delivery of employee payroll checks; production of internal accounting records and administration reports; preparation of federal, state, and local payroll tax returns; and collection and remittance of clients payroll obligations.
PDL BioPharma Inc (NASDAQ:PDLI)’s shares gained 1.74% to $5.27.
PDL BioPharma, Inc. (PDLI) declared that it has reached a credit agreement with CareView Communications, Inc. (CRVW) whereby PDL will provide CareView with up to $40 million of secured debt financing. CareView is an information technology provider to the healthcare industry focused on patient care monitoring.
Under the credit agreement, PDL will provide CareView with up to $40 million of debt financing in two tranches of $20 million, based upon the achievement of specified milestones. Each tranche has a five year maturity. PDL will receive interest on the principal amount outstanding and has a security interest in substantially all of CareView’s assets. As part of the transaction, PDL received a warrant to purchase about 4.4 million shares of common stock of CareView at an exercise price of $0.45 per share.
PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases.
At the end of Tuesday’s trade, LinkedIn Corp (NYSE:LNKD)‘s shares surged 0.02% to $183.22.
LinkedIn Corporation (LNKD), the world’s largest professional network on the Internet, declared recently the launch of a new quarterly series, LinkedIn Lists, which celebrates different types of members and companies that are doing extraordinary work and transforming their fields.
The first list in the series focuses on the LinkedIn Next Wave, which spotlights the top 150 professionals across 15 industries — all 35 and under. Like all of LinkedIn’s content efforts, the Next Wave derived from a partnership between editors and algorithms: How can the data assist find the leaders you may not know about — but should. We also asked LinkedIn Influencers, ~500 top minds in business who write and share on LinkedIn, for their recommendations.
LinkedIn Corporation, together with its auxiliaries, operates an online professional network worldwide. The company, through its proprietary platform, allows members to create, manage, and share their professional identity online; build and engage with their professional netoperates; access shared knowledge and insights; and find business opportunities.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
